Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection

Breast

Volumn 15, Issue 3, 2006, Pages 451-454

  Engel, J ^a   Lebeau, A ^b   Sauer, H ^a   Holzel D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Axilla dissection; Breast cancer; Sentinel technique

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BEHAVIOR CHANGE; BREAST CANCER; CANCER SURGERY; HUMAN; LYMPH NODE DISSECTION; METASTASIS; PECTORAL MUSCLE; PRIORITY JOURNAL; PROBABILITY; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; SYSTEMIC DISEASE; AXILLA; BREAST TUMOR; FEMALE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORTALITY; PATHOLOGY; PROGNOSIS;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 33744919035     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.05.009     Document Type: Article

References (28)

1. Nestl A., Von Stein O.D., Zatloukal K., et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 61 4 (2001) 1569-1577
2. Bernards R., and Weinberg R.A. A progression puzzle. Nature 418 6900 (2002) 823
3. Tait C.R., Dodwell D., and Horgan K. Do metastases metastasize?. J Pathol 203 1 (2004) 515-518
4. Van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
5. Michaelson J.S., Silverstein M., Wyatt J., et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95 4 (2002) 713-723
6. Engel J., Eckel R., Kerr J., Schmidt M., Fürstenberger G., Richter R., et al. The process of metastasisation for breast cancer. Eur J Cancer 39 12 (2003) 1794-1806
7. Chu K.U., Turner R.R., Hansen N.M., Brennan M.B., Bilchik A., and Giuliano A.E. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg 229 4 (1999) 536-541
8. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 7 (1997) 2483-2493
9. Veronesi U., Marubini E., Mariani L., Valagussa P., and Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 35 9 (1999) 1320-1325
10. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347 8 (2002) 567-575
11. Fowble B., Hanlon A., Freedman G., et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47 4 (2000) 883-894
12. Louis-Sylvestre C., Clough K., Asselain B., et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22 1 (2004) 97-101
13. Sinha P.S., Thrush S., Bendall S., and Bates T. Does radical surgery to the axilla give a survival advantage in more severe breast cancer?. Eur J Cancer 38 11 (2002) 1474-1477
14. Janni W., Rack B., Sommer H., et al. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. J Cancer Res Clin Oncol 129 9 (2003) 503-510
15. Canavese G., Catturich A., Vecchio C., et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 24 2 (1998) 104-109
16. Tanis P.J., Nieweg O.E., Valdes Olmos R.A., et al. Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 87 7 (2002) 705-710
17. Chagpar A., Middleton L.P., Sahin A.A., et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer (2005)
18. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 2 (2005) 231-237
19. Sant M., Allemani C., Capocaccia R., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106 3 (2003) 416-422
20. Maggard M.A., Thompson J.E., and Ko C.Y. Why do breast cancer mortality rates vary across states?. Am Surg 69 1 (2003) 59-62
21. Engel J., Kerr J., Schlesinger-Raab A., Eckel R., Sauer H., and Holzel D. Predictors of quality of life of breast cancer patients. Acta Oncol 42 7 (2003) 710-718
22. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 9165 (1999) 1641-1648
23. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 2 (2005) 116-126
24. Veronesi U., Orecchia R., Zurrida S., et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 16 3 (2005) 383-388
25. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis. Ann Surg Oncol 6 1 (1999) 109-116
26. Bland K.I., Scott-Conner C.E., Menck H., and Winchester D.P. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188 6 (1999) 586-595 discussion 595-6
27. Morrow M. A survival benefit from axillary dissection: was Halsted correct?. Ann Surg Oncol 6 1 (1999) 17-18
28. Morrow M. Is axillary dissection necessary after positive sentinel node biopsy? Yes!. Ann Surg Oncol 8 9 Suppl (2001) 74S-76S